据港交所12月16日披露，卓正医疗控股有限公司(卓正医疗)通过港交所主板上市聆讯，海通国际和浦银国际为联席保荐人。 中高端医疗服务是指综合性定制服务，强调患者体验及服务质量，并可进一步分为公立中高端医疗服务及私立中高端医疗服 务。大众富裕人群是指人均年可支配收入超过人民币200,000元的人口群体。于2024年，私立中高端医疗服务机构占中国中高 端医疗服务市场总收入约66.5%及中国医疗服务行业总收入约5.6%。 另外，根据弗若斯特沙利文的数据，中国私立中高端医疗服务市场的总收入由2020年的人民币1,930亿元按 21.9%的年复合增长 率增加至2024年的人民币4,263亿元，且预计2024年至2029年将继续按年复合增长率14.3%增长，于2029年达到人民币8,314亿 元。根据弗若斯特沙利文的资料，按 2024年的收入计，公司在更广泛的中高端医疗服务市场的市场份额约为0.1%。 凭借集中化、标准化及数字化的管理系统，卓正医疗建立了覆盖中国部分经济最发达城市的网络，包括深圳、广州、北京、成 都、苏州、长沙、上海、重庆、杭州及武汉。截至2025年10月28日，公司在中国各地拥有及经营19家医疗服务机构， ...

Core Insights - Jiangsu Cancer Hospital and Huai'an Cancer Hospital successfully performed two remote surgeries using 5G robotic technology, allowing local patients to access high-quality medical resources without leaving their city [1][2] Group 1: Remote Surgery Implementation - The first surgery involved the removal of two kidney lesions, completed in about one hour with no operational delays, providing a seamless experience similar to traditional robotic surgeries [2] - The second surgery focused on the removal of multiple lung nodules, with the largest nodule measuring approximately 1.5 centimeters, and was completed in about 30 minutes [2] Group 2: Training and Collaboration - Jiangsu Cancer Hospital has been providing ongoing support to Huai'an Cancer Hospital through management and expert teams, enhancing local medical capabilities over the past three years [3] - A systematic support plan was established to ensure the safety of remote surgeries, including advanced equipment and hands-on training for local medical staff [3] Group 3: Future Developments - Jiangsu Cancer Hospital has been approved as a national training base for AI-assisted treatment technologies, aiming to integrate AI deeply into cancer diagnosis and treatment [3][4] - Future developments in robotic surgery will focus on remote medical services and automated surgeries, with plans to implement "one-to-many" and "many-to-one" models for enhanced resource utilization [4]

Core Insights - The Yangzhou University Medical Innovation Development Forum announced the official launch of the Yangzhou University Affiliated Hospital Jinghu Advanced Medical Center, aiming to enhance medical education and healthcare services in Yangzhou [1] Group 1: Medical Education and Collaboration - The forum focused on gathering consensus and wisdom to outline future plans, emphasizing medical education, technological innovation, and healthcare services [1] - A strategic cooperation agreement was signed between the Yangzhou Health Commission and the Yangzhou University Medical School to improve regional healthcare service quality [1] - Yangtze River Pharmaceutical Group signed a collaboration agreement with the Yangzhou University Medical School to enhance industry-academia cooperation and result transformation [1] Group 2: Advanced Medical Center Operations - The Jinghu Advanced Medical Center will integrate high-quality medical resources from across the country, particularly from Beijing and Shanghai [1] - The center aims to provide more precise, efficient, and humanized medical services through a "pre-diagnosis" and multidisciplinary joint diagnosis model [1] - Future plans include promoting the distribution of quality medical resources and enhancing regional healthcare service capabilities [1]

Core Viewpoint - International Medicine (000516) has experienced a decline in both revenue and net profit for the first three quarters of 2025, indicating potential challenges in its business performance [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue was 2.995 billion yuan, a year-on-year decrease of 16.94% [2]. - The net profit attributable to shareholders was -294 million yuan, down 38.45% year-on-year [2]. - The net profit after deducting non-recurring items was -312 million yuan, a decline of 41.94% year-on-year [2]. - In Q3 2025, the company's single-quarter main revenue was 961 million yuan, a year-on-year decrease of 18.95% [2]. - The single-quarter net profit attributable to shareholders was -129 million yuan, a significant drop of 234.24% year-on-year [2]. - The single-quarter net profit after deducting non-recurring items was -123 million yuan, down 52.03% year-on-year [2]. - The company's debt ratio stood at 68.8%, with investment income of 20.7586 million yuan and financial expenses of 111 million yuan [2]. - The gross profit margin was 6.59% [2]. Market Activity - As of December 16, 2025, the stock closed at 4.5 yuan, down 1.1%, with a turnover rate of 0.52% [1]. - The trading volume was 113,800 hands, with a transaction amount of 51.2548 million yuan [1]. - On December 16, the net outflow of main funds was 4.082 million yuan, accounting for 7.96% of the total transaction amount [1]. - The net outflow of speculative funds was 1.8504 million yuan, representing 3.61% of the total transaction amount [1]. - Retail investors had a net inflow of 5.9323 million yuan, making up 11.57% of the total transaction amount [1]. Analyst Ratings - In the last 90 days, two institutions have given ratings for the stock, both recommending an increase in holdings [3]. - The average target price set by institutions in the past 90 days is 5.5 yuan [3].

（来源：吴说） 医疗健康及比特币金库公司 KindlyMD（NAKA）表示，其股价已连续 30 个交易日低于 1 美元，纳斯 达克已发出退市风险通知。公司需在 6 月 8 日前使股价连续 10 个交易日收于或高于 1 美元，以恢复合 规。KindlyMD 于 8 月通过反向并购完成重组，目前持有 5,398 枚比特币。该股在交易宣布后曾大幅上 涨，但此后回落，周一收于 0.38 美元。（CoinDesk） 来源：市场资讯 ...

Group 1 - The core viewpoint of the article is that Tongce Medical (600763) has disclosed its total number of shareholders, which is 98,000 as of December 10, 2025 [1] - The company emphasizes the importance of fair information access for all investors and states that future updates on shareholder numbers will be provided in its official periodic reports [1]

Core Insights - InnovAge Holding Corp. (INNV) shares increased by 7.8% to close at $5.82, driven by higher trading volume and an overall gain of 11.6% over the past four weeks [1][2] Financial Performance - In fiscal Q1 2025, InnovAge reported total revenues of $236.1 million, reflecting a year-over-year increase of approximately 15.1% [2] - The company achieved a net income of $7.7 million, a significant turnaround from a net loss of $5.7 million in the same quarter last year [2] Earnings Expectations - InnovAge is projected to report quarterly earnings of $0.04 per share, indicating a year-over-year growth of 140% [3] - Expected revenues for the upcoming quarter are $228.16 million, which represents a 9.2% increase from the previous year [3] Earnings Estimate Revisions - The consensus EPS estimate for InnovAge has been revised 20% higher in the last 30 days, suggesting a positive trend that typically correlates with stock price appreciation [4] - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [4] Industry Context - InnovAge is part of the Zacks Medical Services industry, where another company, Danaher (DHR), saw a 1% increase in its stock price, closing at $228.53, with a 2.3% return over the past month [4] - Danaher has a Zacks Rank of 4 (Sell), with its EPS estimate remaining unchanged at $2.14 compared to the previous year [5]

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION   (a)Full name of discloser:Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b)Owner or controller of interests and short ...

证券日报网讯 12月16日，睿智医药在互动平台回答投资者提问时表示，公司严格按照相关法律法规履 行信息披露义务，如签订达到披露标准的重大合同，公司将严格按照监管要求及时进行公告。股价受宏 观经济、行业政策、市场情绪等多重复杂因素共同影响。公司管理层始终专注于主营业务，致力于通过 提升经营管理效率和核心竞争力，以扎实的业绩和长期的成长回报广大投资者的信任。 （文章来源：证券日报） ...

根据大数据筛查线索，惠州市龙门县医疗保障局调查发现，惠州市龙门县龙城街道社区卫生服务中心存 在违反诊疗规范、过度开展诊疗行为，导致医保基金不当支出，造成医保基金损失。 依据《医疗保障基金使用监督管理条例》有关规定，龙门县医疗保障局责令该机构立即改正违法行为， 并依法处以行政处罚。目前，涉案医保基金已全部追回，龙门县纪委监委已对龙城街道社区卫生服务中 心的4名相关责任人进行立案处理。 近日，惠州市医疗保障局在官网公布2批共5例医保基金典型案例，涵盖参保人骗保、医疗机构违规诊 疗、药店重复收费等类型，旨在通过以案释法强化监管震慑，坚决守护医保基金 "救命钱"。 案例1 参保人隐瞒第三方责任骗保，获刑并退缴违法所得 根据部门联合数据比对线索，惠州市惠城区医疗保障局通过与惠城区检察机关、公安机关的协同核查发 现：参保人曾某某因交通事故受伤就医，在明知存在第三方责任的情况下，隐瞒事故事实，在医保报销 时故意填写"无第三方责任承诺书"，违规报销医保基金8115.9元，其中5681.13元依法应由第三方承担 （即骗取医保基金5681.13元），构成骗取医保基金行为。 经多次责令其退款未果后，医保部门依据《中华人民共和国行政 ...